Conference Notes

Synthetic Bio-Technology to Boost Green Chemicals Production by Guy Hélin

The start-up focusing on applications of micro-organisms to industry, using the tools developed initially to decode the human genes in labs.

Key Issue for industrial biotech companies is gene containment which requires a gene firewall which Syngulon developed based on bacteriocins. Syngulon owns a fully patented technology enabling gene containment and genetic shielding for industrial biotech. Syngulon are looking for industrial partners to join the PARAGEN project financed by the Belgium Wallonie Region.

RELATED ARTICLES

%d bloggers like this: